News

Orion Adds Industry Leader to Board

Ottawa, Canada, Aug. 31, 2021 (GLOBE NEWSWIRE) — Orion Biotechnology, a clinical stage company that is developing novel G Protein-Coupled Receptor (GPCR)-targeted therapeutics for the treatment of cancer and other serious diseases, today announced the

Read More »

Global Headquarters

343 Preston Street

11th floor,

Ottawa, On K1S 1N4

CANADA

+1 343.291.1032

Switzerland

Campus Biotech

Innovation Park

Avenue de Sécheron 15

1202 Genève

SWITZERLAND

Poland

Orion Biotechnology

Life Science Park

UI Bobrzyńskiego 14

30-348 Krakôw

POLAND

© 2023 Orion Biotechnology Canada, Ltd. All rights reserved.

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

+1 343.291.1032

This website uses cookies to ensure you get the best experience on our site.  By using this website, you agree to our use of cookies.

contact us

Leave  us a message and we will try to respond by the next business day

ORION Logo Pantone(375x133)

Our Headquarters

343 Preston Street

11th floor,

Ottawa, ON K1S 1N4

CANADA

info@orionbiotechnology.com

+1 343.291.1032